Abstract. Little is known about the dynamics of pathology due to schistosomiasis following treatment. Public health authorities in endemic areas require such information to decide on the timing of treatment and re-treatment schedules. A study to assess the rate of clearance and reappearance of pathologic lesions due to Schistosoma haematobium using ultrasound has now been carried out in two schools in southeastern Tanzania, an area of moderateto-high transmission. Baseline data collection found urinary tract pathology in 67% of 533 children. Lesions of the bladder were significantly associated with egg positivity and microhematuria. The attributable fraction estimate of major bladder lesions due to S. haematobium was 75%. In a cohort study, 224 infected children were examined by ultrasound and then treated with a standard dose of 40 mg of praziquantel/kg of body weight. They were re-examined at two, four, six, 12, 18, and 24 months after treatment. Before treatment, 76% had pathologic lesions of the urinary tract. The proportion showing lesions decreased sharply during the first months after treatment to 11% at six months. At 24 months, lesions were detected in 57%, and 11% had developed new severe pathology. In 18 cases, pathology was present throughout, and 34 did not show any pathology throughout the study. This study provides the first detailed report on the evolution of urinary tract pathology due to S. haematobium infections at the community level. The results will help in making decisions on treatment and re-treatment schedules and more generally will provide a basis for designing control strategies in areas of moderate-to-high transmission.
Various measures are used to assess infection and pathology due to Schistosoma haematobium. 1 Egg counts are the standard indirect morbidity parameter measuring infection. Hematuria detected by reagent strips is another indirect measurement of urinary tract lesions in S. haematobium infections. Currently, schistosomiasis control programs in endemic areas aim at reducing morbidity in the population, 2 so it is important to document the prevalence of pathologic lesions before and after interventions. Ultrasound scanning of the urinary tract provides visible evidence of pathology. It is a safe tool that can be used in the field and is reliable, especially in detecting significant pathology. 3 The dynamics of clearance of pathologic lesions within six months after effective treatment with praziquantel in areas of mild-to-moderate transmission have been documented by Hatz and others using ultrasound. 4 Little is known about the dynamics of pathology after clearance in areas with continuous re-exposure. Such information is clearly required to reach informed decisions on treatment and re-treatment schedules. Based on previous experience in the same area, 4 the present study was designed to assess the evolution of pathology after treatment, and the severity and the incidence of reappearance of lesions due to S. haematobium in an area of moderate-to-high transmission over a period of two years.
Pathology due to S. haematobium infection has been found to be specific in endemic areas. Few confounding diseases mimic the typical lesions seen in the urinary tract. The association between pathologic lesions detected by ultrasound and measures of infection have also been documented. 5 However, there are no published estimates of the extent to which different pathologic lesions associated with schistosomiasis can be attributed to infection determined by egg output or hematuria measurements. Recent work by Guyatt and others 6 and Booth and others 7 has demonstrated the usefulness of calculating such attributable fraction estimates. This paper also includes this approach and presents these calculations as well as predictive values.
STUDY POPULATION AND METHODS
Baseline survey. The collection of baseline data was carried out in 533 subjects attending the Mikumi (n ϭ 341) and Msimba (n ϭ 192) primary schools in the Kilosa District in southeastern Tanzania, an area of documented moderate-tohigh transmission of S. haematobium. 8 Oral informed consent was obtained from the children and their parents or care takers. Research and ethical clearance was granted by the Medical Research Board Coordination Committee of the National Institute for Medical Research through the Tanzanian Commission of Science and Technology and the Danish Central Medical Ethics Committee.
All infected pupils received a single dose of 40 mg of praziquantel/kg of body weight in March 1993 at the end of the main transmission season. Praziquantel (40 mg/kg) was given again to all infected children at 24 months.
A history of hematuria at the time of the investigation was recorded. Urine filtrations were performed on five consecutive days between 10:00 AM and 2:00 PM for eggs/10 ml, using Nucleopore membranes (12 m) (Costar, Cambridge, MA). 9 Microhematuria was assessed on five consecutive days using reagent strips (Boehringer Mannheim, Mannheim, Germany) (grades 0 to 3; 0 ϭ negative; 1 ϭ ϳ5-10 red blood cells [RBC]/l; 2 ϭ ϳ50 RBC/l; 3 ϭ ϳ250 RBC/ l). The highest of the five values of egg counts and microhematuria for each individual were used for statistical analysis.
Full ultrasound investigations of the urinary tract were performed in all subjects. Two Aloka (Tokyo, Japan) SSD- 10 Congestive changes of the kidneys were recorded according to standards proposed by the Cairo working group. 10 Ureter dilatation was assessed at the lower and upper ends. All children with hydronephrosis were asked to empty their bladders and were re-examined to avoid misinterpretation of physiologic findings. 11 Staging of urinary tract pathology is shown in Table 1 . Any pathology of the ureter and kidneys, referred to as upper urinary tract lesions, is the result of obstruction due to spacefilling lesions in the trigone area of the bladder or in the ureters. Such lesions were considered as moderate pathology because they are predictors of hydronephrosis.
Overall pathology included all stages of pathology detected. Major bladder lesions were defined as diffuse irregularities and/or diffuse thickening of the bladder wall, or the presence of at least one mass or pseudopolyp. They corresponded to the moderate and severe stages described in Table 1. Moderate and severe pathology are referred to as major pathology in this report.
Cohort survey. From 437 children with positive egg counts or microhematuria, a cohort of 224 who were seen at the baseline and at all six follow-up surveys between March 1993 and March 1995 was evaluated. Age, sex, pathology as measured by ultrasound, and distribution of infection as measured in the laboratory did not differ significantly between the two schools. Consequently, the results were pooled for the analysis.
Fifty-two children with heavy infections (Ն 50 eggs/10 ml of urine), macrohematuria, or major pathologic lesions of the urinary tract were treated with praziquantel (40 mg/kg) at 18 instead of 24 months. The study protocol already foresaw the treatment of children with macrohematuria and/or severe pathology if this was necessary during the course of the study. Assuming that none of the lesions present at 18 months would have cleared within the last six months of the study, urinary tract lesions detected in the 52 subjects treated at 18 months were considered identical at 24 months, irrespective of their development after treatment. An estimation of the amount of pathology at 24 months after treatment could thus be calculated.
Statistical analysis. Frequency distributions were calculated for all variables to obtain an insight into the distribution of their individual values over time. Pearson's chisquare test was used to assess associations between the different measures of pathology, infection, and sex. Logistic models were applied to determine the significance of age on pathology measures. The log-rank test was applied to compare the time of clearance between bladder and kidney pathology over the first six months after treatment as well as to assess whether the clearance rate of pathology was ageor sex-dependent.
Predictive values of different egg count thresholds in defining pathology were calculated at baseline and follow-up investigations to detect pathology. Relative risks between infection (egg positivity) and pathology (ultrasound findings) were calculated to assess the association between infection and pathology.
Attributable fractions were estimated from baseline data to determine the proportion of different types of pathology that could be attributed to infection. For each pathology class, the relative risk associated with infection was computed by dividing the prevalence of pathology among infected children by the prevalence among uninfected children. Confidence limits were estimated from the test method of Miettinen, as described by Kirkwood. 12 The attributable fraction among the infected was then estimated as the ratio of the excess risk of pathology among the infected to the total risk. Age-adjusted estimates of attributable fractions were calculated using the weighted sum method 13 with age as a weighting variable whenever the association between pathology and infection measures was age-dependent. Variance and confidence limits of these weighted estimates were obtained as previously described. 6, 7 
RESULTS
Baseline survey. The mean age of the 533 children was 11.5 years (range ϭ 7-18 years), the male:female ratio was 0.9. The mean age of boys (11.8 years, range ϭ 7-17) was significantly higher than that of girls (11.2 years, range ϭ 7-15; P ϭ 0.0008, by Kruskal-Wallis test).
Schistosoma haematobium eggs were detected among 77% of the 533 children in at least one of five urine samples.
The intensity was high, with 51.1% showing Ն 50 eggs/10 ml of urine (40% Ն 100 eggs/10 ml of urine). This was reflected in the fact that 82% had microhematuria (96% with grades 3 or 4), and 7% had visually detectable hematuria. Forty-two percent reported to have noticed hematuria during the previous two weeks.
Pathologic lesions of the urinary tract were detected by ultrasound in 67.2% of the children ( Table 2) . Calcifications of the urinary tract or liver lesions were not detected. Kidney fibrosis was not recorded. Lesions of the bladder were significantly associated with egg output ( 2 1 , ϭ 28.61, P Ͻ 0.0001) and with microhematuria ( 2 1 , ϭ 13.85, P ϭ 0.0002).
Age was significantly associated with pathology. Estimated odds ratios showed that each year increase in age was associated with a relative risk of 1.17 (95% confidence interval [CI] ϭ 1.064, 1.292) for pathologic lesions. The relative risk for infection was 1.23 (95% CI ϭ 10.97, 1.374). Pathologic lesions were found significantly more frequently among older than younger girls, but the difference was not significant among boys. Major bladder lesions were associated with upper urinary tract pathology ( 2 1 ϭ 5.06, P ϭ 0.02) and were found more often among boys than among girls ( 2 1 ϭ 4.86, P ϭ 0.03). Intensity of egg output and the prevalence of microhematuria did not differ significantly between the two sexes.
Sensitivity of egg excretion for overall pathology was 87%. Sensitivities of measured and anamnestic hematuria were Ͼ 65% for overall pathology and bladder pathology. Visual hematuria was sensitive for detection of bladder lesions both at the baseline (92%) and at 18 months (75%). Specificity of eggs for kidney pathology was greater than 96% in both egg classes (Ͼ 0 and Ն 5 eggs/10 ml of urine).
Attributable fraction (AF) estimates in the baseline survey are listed in Table 3 . Since bladder pathology, overall pathology, and major pathology were age-dependent, the relevant attributable fractions were adjusted for age. Attributable fractions were higher with major and severe pathology than with overall pathology classes. When microhematuria measurements instead of egg counts were taken as reference standards for morbidity, AFs of pathology were lower. When egg counts and/or microhematuria were combined as infection markers, AFs were slightly higher than with egg count alone for major pathology and lower for overall bladder lesions.
Cohort survey. Parasitologic and ultrasound findings were recorded in 224 children at baseline and at six followup examinations over 24 months after treatment. No differences between the baseline group and the cohort were recorded with regards to age and sex. Initially, 93.8% and 97.8% of the cohort subjects had positive egg counts and microhematuria, respectively.
The potential of two different egg count measurements (Ͼ 0 and Ն 50 eggs/10 ml) to predict pathologic lesions before and after treatment are shown in Table 4 . Results in the first two surveys after treatment were very low. Negative predictive values were high at six and 18 months, partly as a reflection of the low prevalence of pathologic lesions. The positive predictive values were 30% and 86% of the baseline value at 12 months and 24 months.
At baseline, 54 children (24.1%) were egg-positive, but no pathology was recorded; 34 did not develop any lesions over the study period. Lesions appeared in 20 children who had no lesions at the beginning of the study (Table 5) . Six of them developed severe pathology.
Ultrasound showed that 170 children (75.9%) had pathologic lesions (12.5% severe) at baseline. Bladder lesions were found in 71.2%, of which 53.2% were major lesions. Pathologic lesions of the ureters and the kidneys were found in 11.2% and 16.5% of all cases. The evolution of pathologic lesions and egg counts after treatment is shown in Figure 1 . Lesions resolved over the first six months in 88% and by 24 months in 96% of all cases. Resolution tended to be higher in younger than in older children (90% versus 85%). Pathologic lesions appeared subsequently in 57.1 % of the study children at 24 months, 75.3% of those with pathologic lesions at day 0. Reappearance was the same in older and younger children (62% versus 59%).
Clearance of pathologic lesions of the bladder (n ϭ 157) and the kidneys (n ϭ 37) over six months after treatment ( Figure 2 ) was not significantly different (log rank 2 1 ϭ 0, P ϭ 0.976). Egg output was higher in cases with pathology and was independent of age or sex.
The evolution of cases with and without reappearance of pathology over time is listed in Table 5 . Sixty-one children (36%) cleared pathology over 18 months and had no new lesions at 24 months. Ninety-one children (54%) cleared pathology, but developed new lesions. New pathology was less severe in 24 cases, the same in 41, and worse in 27. Twelve of the 92 children developed major pathology. Pathologic lesions were not cleared over 24 months in 18 children (10.6%). Severe pathology did not persist in any of the cases; it improved in six and remained the same in eight. In four children there was post-treatment improvement, but pathology then became worse and three children developed new severe pathology.
Children with severe pathology at baseline developed new severe pathology significantly more often than children without or with mild pathology at baseline (Table 6) .
Children who developed pathology during the study period but had no pathology at baseline had significantly higher egg counts at 12 and 18 months than those who cleared pathology within four months and did not have a reappearance (P Ͻ 0.05, by Wilcoxon test).
DISCUSSION
Knowledge about resolution and reappearance of morbidity due to schistosomal infections is crucial for the design of rational and cost-effective morbidity control strategies that will minimize lasting damage of the affected tissues. The treatment and re-treatment schedules needed will be influenced by a variety of factors, including duration and intensity of exposure. The time intervals when re-treatment becomes necessary depend ultimately on the transmission pattern in a given endemic setting. Ultrasound can visualize pathologic lesions at community level and is therefore a valuable tool for assessing the amount of schistosomal morbidity and following its dynamics after treatment.
The high and intense transmission of S. haematobium infections in the study area is reflected by the fact that more than half of the children in the baseline survey had heavy infections and two of three children had pathologic lesions. As expected in this area, 10 older children had pathologic lesions more frequently than younger children and they were more severe. Boys had more pathologic lesions than girls, irrespective of age, but this was not significant. Girls 12 year of age and older had significantly more lesions of the urinary tract than younger ones. Differences in the duration of exposure to infection are the most likely explanation for this observation. Although genital lesions were not investigated in this study, experience from other studies 14, 15 suggests that a substantial amount of such pathology probably also exists.
There was a strong association between indirect morbidity indicators and pathologic lesions of the urinary tract. As expected, severe pathology was highly associated with egg output. However, the attributable fraction for bladder pathology was relatively low. The high prevalence of pathologic findings may be one explanation for this observation; lesions unrelated to schistosomiasis may be another. Among the large number of lesions found, there may have been some individuals that were not shedding eggs at the time of observation. After efficacious treatment and reinfection, egg output is detected earlier than new lesions.
Visual hematuria had a high sensitivity in detecting bladder pathology at the beginning of the study and towards the end of the observation period. This may prove to be a reliable, though crude, parameter of pathologic lesions of the urinary tract if ultrasound is not available.
Continuous exposure, the duration of infection before treatment, and the development of immunity over time are key determinants of schistosomal morbidity. There have been several reports on resolution of S. haematobium-related pathology after treatment using conventional radiographic and ultrasound techniques. 10, 16, 17 This study presents the first detailed report on reappearance of pathology due to reinfection in an area of high transmission. In the 224 children, rapid clearance of most eggpositive cases and pathologic lesions was achieved after treatment with praziquantel at a dosage of 40 mg/kg of body weight. Reappearance of positive egg counts started between six and 12 months after treatment and was followed by the reappearance of pathologic lesions approximately six months later. When the same analysis of the data was performed as in a similar study in Ghana (Wagatsuma Y, unpublished data), there was no significant difference in the resolution and reappearance of pathologic lesions between younger and older children. This was most probably due to high exposure to reinfection in all age groups in the present study. Children with severe pathology were more likely to develop lesions again, which may indicate that those children were more susceptible to severe pathology than children with mild or moderate pathology. However, caution is warranted in interpreting these observations because no data on exposure were collected.
The proportion of pathology at 24 months was 76% of the baseline figure recorded among the originally infected children in the cohort. Forty-six percent of these children had major pathology. Thus, almost half of the cohort children who were infected at baseline again had severe lesions requiring treatment after two years. Resolution and reappearance of pathologic lesions was not statistically different between sex and age. The prevalence of severe pathology among the cohort was 12.9% at baseline, whereas it was 6.8% among the 533 children originally studied. Although this difference is likely to be due to selection bias, it may also indicate that the exposure of the originally infected cohort could have been higher. Some of the children had been treated for schistosomiasis at the local health facility within one year prior to the study.
Development of major pathology was recorded significantly more often among children with no lesions at baseline than among those with reappearance of lesions after clearance. This observation raises the question to what extent subjects who had recently cleared schistosomal lesions of the urinary tract are protected from severe pathology.
The positive predictive potential of two different levels of egg counts for pathology among the cohort over time provides a valuable insight into the reinfection dynamics. Pretreatment figures are similar to the ones after 24 months, indicating that this parameter could be used in the absence of ultrasound information as an indirect marker of pathology. The predictive potential at 6-18 months is considerably lower because treatment affects the relationship between egg output and pathologic lesions of the urinary tract at early stages of the reinfection cycle.
Older children were found to be egg-positive more often. While we accept that exposure is one key factor determining morbidity, this does not alone explain the variation in the level of clinical disease detected among the study group. Host factors are likely to influence the development of pathologic lesions. Genes controlling S. haematobium infection levels may determine whether a person develops severe clinical disease. This has been postulated for S. mansoni infections (Dessein AJ, University of Marseille, Marseille, France, unpublished data). Further studies are warranted to investigate this question further.
Major pathology did not persist in any case throughout the observation period. All major pathologies responded to treatment, and major pathology at the end of the study period was also substantially related to new infections.
The results show that pathology reappears after 12 months following efficacious treatment. Some severe pathology requiring treatment appeared at 18 months and the incidence increased to 11% at 24 months. On the basis of our findings in this setting, re-treatment is indicated at 18-24 months after initial treatment with praziquantel to prevent further development of severe disease among a subset of this cohort. The value of arbitrarily chosen cut-off points, such as 50% for overall pathology and 10% for severe pathology due to S. haematobium, should be evaluated in different endemic settings to determine whether they are appropriate markers for proposing re-treatment intervals. This question relates to different prevalence-intensity relationships in different endemic settings. 18 Where such investigations and interventions are not feasible, we propose, based on the experience in this study, two mass treatment rounds among school children in endemic areas. A substantial amount of pathology was detected among the younger children in this setting. These findings justify early treatment. The first mass treatment should be conducted at 7-9 years of age and a second one at 15-18 years of age. Such a schedule is likely to prevent the development and persistence of severe urinary tract pathology and genital lesions.
